ArticleTherapeutic advances in neurological disorders2026
Efficacy and safety of glucagon-like peptide-1 receptor agonists in Parkinson's disease: a systematic review and meta-analysis of randomized placebo-controlled clinical trials.
Maria-Ioanna Stefanou et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.